Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR)

Fig. 3

Survival curves from Cox-proportional hazards models for death or myocardial infarction (MI) according to renin-angiotensin system inhibitors treatment between 1-year to 3-year after an acute myocardial infarction. RASI, renin-angiotensin system inhibitors; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us